Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don Husereau

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Applied Health Economics and Health Policy|January 11, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task ForceDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Health Services Research|January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Health Policy OPEN|June 29, 2023
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTAFinn Børlum Kristensen, Don Husereau, Mirjana Huić, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Guidelines for health technologies: specific guidance for oncology products in CanadaNicole Mittmann, William K Evans, Angela Rocchi, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationAmbica Parmar, Wei Fang Dai, Francois Dionne, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Applied Health Economics and Health Policy|January 11, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task ForceDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Health Services Research|January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Health Policy OPEN|June 29, 2023
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTAFinn Børlum Kristensen, Don Husereau, Mirjana Huić, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Guidelines for health technologies: specific guidance for oncology products in CanadaNicole Mittmann, William K Evans, Angela Rocchi, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationAmbica Parmar, Wei Fang Dai, Francois Dionne, et al.
Pageof 9